356 related articles for article (PubMed ID: 15028725)
1. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase.
Kim EK; Miller I; Aja S; Landree LE; Pinn M; McFadden J; Kuhajda FP; Moran TH; Ronnett GV
J Biol Chem; 2004 May; 279(19):19970-6. PubMed ID: 15028725
[TBL] [Abstract][Full Text] [Related]
2. C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism.
Landree LE; Hanlon AL; Strong DW; Rumbaugh G; Miller IM; Thupari JN; Connolly EC; Huganir RL; Richardson C; Witters LA; Kuhajda FP; Ronnett GV
J Biol Chem; 2004 Jan; 279(5):3817-27. PubMed ID: 14615481
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke.
McCullough LD; Zeng Z; Li H; Landree LE; McFadden J; Ronnett GV
J Biol Chem; 2005 May; 280(21):20493-502. PubMed ID: 15772080
[TBL] [Abstract][Full Text] [Related]
4. Role of neuronal energy status in the regulation of adenosine 5'-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior.
Lee K; Li B; Xi X; Suh Y; Martin RJ
Endocrinology; 2005 Jan; 146(1):3-10. PubMed ID: 15375032
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats.
Shimizu H; Arima H; Watanabe M; Goto M; Banno R; Sato I; Ozaki N; Nagasaki H; Oiso Y
Endocrinology; 2008 Sep; 149(9):4544-53. PubMed ID: 18535107
[TBL] [Abstract][Full Text] [Related]
6. A central role for neuronal adenosine 5'-monophosphate-activated protein kinase in cancer-induced anorexia.
Ropelle ER; Pauli JR; Zecchin KG; Ueno M; de Souza CT; Morari J; Faria MC; Velloso LA; Saad MJ; Carvalheira JB
Endocrinology; 2007 Nov; 148(11):5220-9. PubMed ID: 17717055
[TBL] [Abstract][Full Text] [Related]
7. The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator.
Takahashi KA; Smart JL; Liu H; Cone RD
Endocrinology; 2004 Jan; 145(1):184-93. PubMed ID: 14512433
[TBL] [Abstract][Full Text] [Related]
8. Role of hypothalamic adenosine 5'-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia.
Alquier T; Kawashima J; Tsuji Y; Kahn BB
Endocrinology; 2007 Mar; 148(3):1367-75. PubMed ID: 17185376
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated protein kinase activates neuropeptide Y neurons in the hypothalamic arcuate nucleus to increase food intake in rats.
Kohno D; Sone H; Tanaka S; Kurita H; Gantulga D; Yada T
Neurosci Lett; 2011 Jul; 499(3):194-8. PubMed ID: 21658429
[TBL] [Abstract][Full Text] [Related]
10. The effect of AMP-activated kinase activation on gonadotrophin-releasing hormone secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats.
Coyral-Castel S; Tosca L; Ferreira G; Jeanpierre E; Rame C; Lomet D; Caraty A; Monget P; Chabrolle C; Dupont J
J Neuroendocrinol; 2008 Mar; 20(3):335-46. PubMed ID: 18194429
[TBL] [Abstract][Full Text] [Related]
11. The connections between C75 and obesity drug-target pathways.
Kuhajda FP; Landree LE; Ronnett GV
Trends Pharmacol Sci; 2005 Nov; 26(11):541-4. PubMed ID: 16169094
[TBL] [Abstract][Full Text] [Related]
12. Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects.
Hu Z; Cha SH; van Haasteren G; Wang J; Lane MD
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):3972-7. PubMed ID: 15728730
[TBL] [Abstract][Full Text] [Related]
13. Effects of stimulation of AMP-activated protein kinase on insulin-like growth factor 1- and epidermal growth factor-dependent extracellular signal-regulated kinase pathway.
Kim J; Yoon MY; Choi SL; Kang I; Kim SS; Kim YS; Choi YK; Ha J
J Biol Chem; 2001 Jun; 276(22):19102-10. PubMed ID: 11262401
[TBL] [Abstract][Full Text] [Related]
14. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment.
Kim EK; Miller I; Landree LE; Borisy-Rudin FF; Brown P; Tihan T; Townsend CA; Witters LA; Moran TH; Kuhajda FP; Ronnett GV
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E867-79. PubMed ID: 12376313
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic malonyl-CoA as a mediator of feeding behavior.
Hu Z; Cha SH; Chohnan S; Lane MD
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12624-9. PubMed ID: 14532332
[TBL] [Abstract][Full Text] [Related]
16. A role for hypothalamic malonyl-CoA in the control of food intake.
Hu Z; Dai Y; Prentki M; Chohnan S; Lane MD
J Biol Chem; 2005 Dec; 280(48):39681-3. PubMed ID: 16219771
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid synthase gene regulation in primary hypothalamic neurons.
Kim EK; Kleman AM; Ronnett GV
Neurosci Lett; 2007 Aug; 423(3):200-4. PubMed ID: 17709201
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
Rattan R; Giri S; Singh AK; Singh I
J Biol Chem; 2005 Nov; 280(47):39582-93. PubMed ID: 16176927
[TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase plays a role in the control of food intake.
Andersson U; Filipsson K; Abbott CR; Woods A; Smith K; Bloom SR; Carling D; Small CJ
J Biol Chem; 2004 Mar; 279(13):12005-8. PubMed ID: 14742438
[TBL] [Abstract][Full Text] [Related]
20. Estradiol regulates effects of hindbrain activator 5-aminoimidazole-4-carboxamide-riboside administration on hypothalamic adenosine 5'-monophosphate-activated protein kinase activity and metabolic neurotransmitter mRNA and protein expression.
Alenazi FS; Ibrahim BA; Briski KP
J Neurosci Res; 2015 Apr; 93(4):651-9. PubMed ID: 25476093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
